The abstract is read at the publisher; the summary is JClub's.
Impaired-deaminase APOBEC3A mutant A3AR128A drives squamous cell carcinoma in murine epithelium, with tumor formation accelerated by Trp53 loss and linked to 235,790 mutations.
- Why it matters: APOBEC enzymes shape cancer mutation spectra, but modeling their DNA-editing effects is hard because active APOBEC proteins are toxic in experimental systems.
- What they did: The study overexpressed A3AR128A (arginine 128 to alanine) in mouse epithelium, including with concomitant Trp53 loss, then analyzed tumors for pathway alterations and mutational signatures using a catalogue of 235,790 mutations.
- The result: A3AR128A tumors showed frequent NOTCH and RAS-PI3K pathway alterations, recurrent histone H3 gene mutations, and cross-species patterns indicating APOBEC accessibility influences driver gene selection.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.